Table 4.

Relationship between fascin positivity and clinicopathologic characteristics in all patients

Status of fascin expression<75 (n = 55), n (%)>75 (n = 145), n (%)P
Age
    <65 y27 (49.1)72 (49.7)0.943
    ≥65 y28 (50.9)73 (50.3)
Gender
    Male42 (76.4)130 (89.7)0.016
    Female13 (23.6)15 (10.3)
Primary tumor
    T1/T237 (67.3)62 (42.8)0.002
    T3/T418 (32.7)83 (57.2)
Regional lymph nodes
    N029 (52.7)44 (30.3)0.003
    N126 (47.3)101 (69.7)
Distant metastasis
    M049 (89.1)118 (81.4)0.190
    M16 (10.9)27 (18.6)
Stage
    I/IIA/IIB35 (63.6)68 (46.9)0.034
    III/IV20 (36.4)77 (53.1)
Histology
    Well differentiated (G1)16 (29.1)26 (17.9)0.147
    Moderately differentiated (G2)24 (43.6)83 (57.2)
    Poorly differentiated (G3)15 (27.3)36 (24.8)
Location
    Upper11 (20.0)26 (17.9)0.297
    Middle33 (60.0)74 (51.0)
    Lower11 (20.0)45 (31.0)